[Antibody therapy for acute leukemia].
Takeshita
Akihiro
A
D000208:Acute Disease; D000617:Aminoglycosides / Q000737:chemistry / Q000627:therapeutic use*; D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D017322:Clinical Trials, Phase II as Topic; D000079982:Gemtuzumab; D006801:Humans; D007167:Immunotherapy; D007938:Leukemia / Q000473:pathology / Q000628:therapy*; D051379:Mice
D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000079982:Gemtuzumab